Schwannomas are peripheral nerve tumors that typically have mutations in the NF2 tumor suppressor gene. We compared cultured schwannoma cells with Schwann cells from normal human peripheral nerves (NHSC). Both cell types expressed speci®c antigenic markers, interacted with neurons, and proliferated in response to glial growth factor, con®rming their identity as Schwann cells. Schwannoma cells frequently had elevated basal proliferation compared to NHSC. Schwannoma cells also showed spread areas 5 ± 7-fold greater than NHSC, aberrant membrane ruing and numerous, frequently disorganized stress ®bers. Dominant negative Rac inhibited schwannoma cell ruing but had no apparent eect on NHSC. Schwannoma cell stress ®bers were inhibited by C3 transferase, tyrphostin A25, or dominant negative RhoA. These data suggest that the Rho and Rac pathways are abnormally activated in schwannoma cells. Levels of ezrin and moesin, proteins related to the NF2 gene product, merlin, were unchanged in schwannoma cells compared to NHSC. Our ®ndings demonstrate for the ®rst time that cell proliferation and actin organization are aberrant in schwannoma cells. Because NF2 is mutant in most or all human schwannomas, we postulate that loss of NF2 contributes to the cell growth and cytoskeletal dysfunction reported here.
Introduction
Schwann cells are the major supportive cell population in the peripheral nervous system. Tumors comprised almost entirely of Schwann-like cells, called schwannomas, are benign lesions that commonly occur on the vestibular branch of the eighth cranial nerve but can arise anywhere in the periphery (Nance et al., 1993; Kawahara et al., 1988) . Enlarging schwannomas can compress adjacent structures, resulting in deafness and other neurologic problems. Surgical removal of these tumors is dicult, often resulting in increased patient morbidity.
Although schwannomas occur sporadically, they are also the hallmark of the inherited neuro®bromatosis type 2 (NF2) disease (Evans et al., 1992) . Ninety per cent of NF2 patients develop bilateral vestibular schwannomas and/or spinal schwannomas. The NF2 gene is located on chromosome 22 (Trofatter et al., 1993; Rouleau et al., 1993) and mutations in both the inherited mutant NF2 allele and the previously normal allele are detectable in NF2 patient schwannomas (Jacoby et al., 1994 (Jacoby et al., , 1996 Twist et al., 1994) . Sporadic schwannomas from non-NF2 individuals also have NF2 mutations (Jacoby et al., 1994 (Jacoby et al., , 1996 . There is no evidence that mutations in other genes occur in these tumors.
The NF2 gene product is referred to as merlin, which stands for moesin (Lankes and Furthmayr, 1991) , ezrin (Gould et al., 1989) , radixin (Funayama et al., 1991) like protein. Ezrin, radixin and moesin (ERM proteins) link the actin cytoskeleton to transmembrane proteins (Yonemura et al, 1993 (Yonemura et al, , 1998 Tsukita et al., 1994; Serrador et al., 1997) . Merlin and ERM family members localize to plasma membrane regions associated with dynamic actin organization in cultured cells (Berryman et al., 1993; McCartney and Fehon, 1996; den Bakker et al., 1995a,b; Gonzales-Agosti et al., 1996) including Schwann cells. ERM proteins bind actin (Algrain et al., 1993; Turunen et al., 1994) although whether merlin also binds actin is not known. Down-regulation of ERM proteins results in loss of microvilli and loss of substrate adhesion (Takeuchi et al., 1994) . ERM proteins can reconstitute stress ®ber formation and cortical actin polymerization following activation of the small GTP-binding proteins Rho and Rac (Mackay et al., 1997) . Whether merlin also plays roles in the Rho and/or Rac pathways, or in cell adhesion, is unknown.
As loss of NF2 correlates with tumor formation, merlin has been classi®ed as a tumor suppressor (Knudson, 1993) . Merlin immunoreactivity is reduced in both NF2 and non-NF2 schwannomas (Sainz et al., 1994; Hitotsumatsu et al., 1997; Huynh et al., 1997; Gutmann et al., 1997a) , consistent with merlin de®ciency being a common feature of schwannomas. Even sporadic schwannomas without detectable biallelic NF2 mutations lack merlin protein (StemmerRachamimov et al., 1997) . In vitro, overexpression of merlin decreased the growth of ®broblast cell lines (Lutchman and Rouleau, 1995; Tikoo et al., 1994) and transformed rat Schwann cell lines (Sherman et al., 1997) . The function of merlin in normal Schwann cells and how loss of merlin aects schwannoma cell growth is unknown, although it has been demonstrated that normal Schwann cells express merlin (Scherer and Gutmann, 1996; Huynh and Pulst, 1996) . Normal Schwann cells require interaction with axons for proliferation (Salzer et al., 1980) . Schwannoma cells, in contrast, are unassociated with axons (Cravioto, 1969; Jaaskelainen et al., 1994) , suggesting that they have aquired the ability to proliferate independent of axon-derived signals.
Since merlin is a tumor suppressor protein related to the ERM family, we predicted that schwannoma cells, most or all of which lack merlin, would have altered growth and aberrant cytoskeletal organization. As an initial test of this hypothesis, we compared normal Schwann cells and schwannoma cells and found that cells from some schwannomas have altered growth properties, while cells from all of the schwannomas we tested showed dramatic abnormalities in their actin cytoskeletons. These ®ndings are the ®rst report of distinct, quanti®able, cellular phenotypes in cultured human schwannoma cells.
Results

Cells dissociated from schwannomas express Schwann cell markers and retain the ability to interact with neurons
Our ®rst goal was to assure that cells puri®ed and expanded from schwannomas were Schwann cells. Cells from normal human nerve and from schwannomas were immunostained using anti-S100b or anti-p75, markers speci®c for Schwann cells among peripheral nerve cell types. Among all of the normal nerve samples and schwanomas examined in this study, 94 ± 97% of the cells expressed both p75 and S100b (for examples of staining, see Figure 1a ± d). High purity of the cell preparations was maintained during the ®rst through third passages. Beyond passage 4, the number of Schwann cells declined and increasing numbers of S100 negative cells (likely ®broblasts) were evident (not shown). For this reason subsequent experiments were performed using cells at passages P0 to P4.
Neurons and Schwann cells can be cultured together and interactions between the cell types studied (Salzer et al., 1980; Kleitman et al., 1991) . Schwann cells adhere to and align along neuronal processes. Since Schwann cells from schwannomas have lost contact with axons in the tumor environment, we tested whether there were abnormalities in their ability to align with neurites in the co-culture paradigm. Figure 1 (e,f) shows that both NHSC and schwannoma cells, stained brown by DAB reaction product indicating expression of the Schwann cell marker S100b, aligned with axons in co-culture under serum-free conditions. The insets show low magni®cation photographs of toluidine blue stained preparations. Parallel cultures stained with anti-p75 con®rmed that the aligned Schwann cells were of human origin, because the p75 antibody does not recognize rat cells (not shown). By the criteria of positive immunostaining with Schwann cell markers and the functional ability of both cell types to attach to and align with neurons, we conclude that the schwannoma cells we isolated from tumors are Schwann cells.
Schwannoma cells often show increased basal proliferation
As mentioned above, Schwann cell survival and proliferation is regulated by interactions with axons.
Neuregulins, including glial growth factor (GGF), are thought to be components of the axonal proliferative signal for Schwann cells (Morrissey et al., 1995; Marchionni et al., 1993) . Since schwannoma cells survive and proliferate in the absence of axons, we reasoned that they may respond abnormally to such signals. We therefore exposed both NHSC and schwannoma cells to soluble recombinant human GGF2 and measured [ 3 H]thymidine incorporation into S100-positive cells (Table 1) . NHSC and schwannoma cells incorporated [ 3 H]thymidine to a similar degree in response to rhGGF2.
A dramatic dierence among schwannoma cell strains was noted when cells were analysed in de®ned, serum-free N2 medium (Table 1) . Under these conditions, NHSC showed very little thymidine incorporation (1 ± 3% labeling in a 3 day pulse of [ 3 H]thymidine). Two schwannoma cell strains also incorporated low levels of [ 3 H]thymidine (1 ± 4% labeling). In contrast, ®ve other schwannoma cell strains demonstrated higher than normal basal [ 3 H]thymidine incorporation (6 ± 25% of cells labelled), suggesting that some schwannoma cell strains have cell-autonomous increased proliferation.
Schwannoma cells have altered morphology and spreading on dierent substrates
Schwann cells obtained from schwannomas had a morphology that diered from the NHSC. As is evident from the photographs in Figure 1a and b, schwannoma cells, 5 days after plating onto laminin, appeared larger than NHSC. This phenotype was observed in all 18 of the schwannomas evaluated in this study. In addition, schwannoma cells frequently showed multiple small membranous extensions from the cell body and cell processes (arrowhead in Figure  1d ). Schwannoma cells also appeared somewhat larger than NHSC when maintained on plastic dishes coated with poly-l-lysine (not shown). We tested whether this size dierence correlated with a dierence in cell spreading. To quantitate cell spreading, cells from two tumors and one normal specimen were plated onto laminin, collagen I or ®bronectin in the presence of serum, then ®xed and stained with anti-S100b at 3 or 24 h. Spread areas were measured in bright ®eld images. On all three substrates, tumor-derived Schwann cells had 5 ± 7-fold larger surface areas than did NHSC (Figure 2a ). There was also signi®cantly greater variation in the areas of schwannoma cells as compared to NHSC. Using laminin substrate as an example, all NHSC had surface areas 52000 mm 2 , while only 0 ± 0.05% of schwannoma cells measured were below 2000 mm 2 . Further, 50 ± 60% of schwannoma cells were 2000 ± 6000 mm 2 and 40 ± 50% were even larger, measuring 6000 ± 10 000 mm 2 (Figure 2b ). Twenty-four hours after plating, schwannoma cells remained threefold larger than NHSC (Figure 2a ) and maintained heterogeneity in area. The depth of NHSC and schwannoma cells was measured by determining the number of optical sections (stained with BODIPYphalloidin) from the bottom to the top of the cells using confocal microscopy (not shown). Schwannoma cells had similar depths compared to normal Schwann cells.
Cytoskeletal organization is altered in schwannoma cells
As schwannoma cells were more spread than NHSC and cell spreading requires reorganization of actin ®laments, we tested whether abnormalities in F-actin organization were detectable in schwannoma cells. In total, ®ve specimens from normal human nerves and all of the eighteen schwannoma specimens evaluated in this study were labeled with phalloidin to visualize Factin. We compared the staining pattern of normal human and tumor-derived Schwann cells at several times after plating onto laminin in the presence of serum. Fifteen to 45 min after plating, schwannoma cells showed striking polymerized actin staining in membrane rues (Figure 3 ). Nearly all schwannoma cells (495%) showed ruing membranes which were Figure 1 Schwannoma cells express Schwann cell markers and align with neurites. Cells from normal nerves (a,c,e) or schwannomas (b,d,f) were stained with anti-p75NGFR (a,b) or anti-S100b (c,d) . In e and f, cells were plated onto cultures of puri®ed neurons, then stained with anti-S100b and appear brown due to DAB reaction product; axons appear blue due to toluidine blue counterstain. Insets in e and f are low magni®cation photographs of parallel cultures that were stained only with toluidine blue to show axons and Schwann cells. Data are representative of three experiments carried out in duplicate with schwannoma cells from tumors #13, 14, and 15. Bar=10 microns in a ± f; inserts in e and f, bar=30 microns absent in NHSC. NHSC, on the other hand, had spikelike protrusions as early as 15 min after plating which persisted up to 3 h. Stress ®bers started to appear at 30 min in both cell types and, as the stress ®bers appeared in schwannoma cells, the ruing became more punctate.
By 3 and 6 h after cell plating, only 10% of schwannoma cells retained detectable membrane ruing. Both NHSC and schwannoma cells had stress ®bers. At these times, NHSC had few bundles of Factin, while schwannoma cells had many more actin bundles (compare Figure 4a to c). Whereas F-actin bundles in NHSC were usually oriented parallel to the long axis of the cells, bundles in the schwannoma cells were not always well organized and often radiated in numerous directions (see arrow in Figure 4c ). These eects on stress ®bers were observed in cells from all of the 18 schwannomas evaluated in this study. Twentyfour hours after plating, both NHSC ( Figure 4d ) and schwannoma cells (Figure 4e ) had comparable F-actin staining. Thus, the dramatic dierences in cytoskeletal organization that we observed in schwannoma cells are transient.
To determine if the abnormalities in stress ®bers were speci®c to schwannoma cells or characteristic of all Schwann cell tumor cells, we compared phalloidin staining (3 or 6 h after plating) of Schwann cells dissociated from a neuro®broma (Figure 4b ) to that of schwannoma cells (Figure 4c ). The neuro®broma was a plexiform tumor from a patient with a con®rmed diagnosis of NF1, which results from mutations in a chromosome 17 tumor suppressor (reviewed in Gutmann et al., 1997a; . Neuro®broma cells, like NHSC, showed only lightly stained, organized, F-actin ®bers. Thus, actin organization is speci®cally altered in Schwann cells derived from schwannomas.
The aberrant organization of actin associated with the cell spreading response might be stimulated by serum in the culture medium, by interaction of schwannoma cells with matrix proteins, or by both. To isolate these variables, schwannoma cells were plated onto laminin or poly-ornithine in the presence or absence of serum. Actin organization was assessed at 30 min and 3 h after plating. On polyornithine few normal or schwannoma cells adhered. Of cells that did adhere, none had rues and few actin bundles were detected. Binding to matrix proteins thus appears to be crucial in triggering the abnormal cell spreading response of schwannoma cells.
Inhibition of Rho reverses abnormal stress ®ber formation in schwannoma cells showed that actin stress ®ber formation in ®broblasts is regulated via the small GTPbinding protein Rho A, while ruing is regulated by NHSC or schwannoma cells from either passage 2 or 3 were plated onto laminin-coated coverslips, incubated in N2 medium for 2 days, then changed to N2 medium with or without rhGGF2. Entry into S-phase was assessed by incorporation of [ 3 H]thymidine into nuclei after autoradiography. Two hundred S100 positive cells were counted on duplicate coverslips after autoradiography. Data are expressed as the percentage of S100 positive cells that had incorporated [ 3 H]thymidine into nuclei on each coverslip. See Table 2 for details on individual tumor and nerve specimens. As noted in the text, cells from all of these schwannoma specimens showed abnormal actin organization. n.d.=not determined; a indicates vestibular schwannoma from an NF2 patient Figure 2 Schwannoma cells dier from normal Schwann cells in extent of cell spreading on matrix proteins. In (a), a representative NHSC specimen and a representative schwannoma (#5) were plated onto laminin, collagen I or ®bronectin for 3 h, cells were ®xed and stained with anti-S100b, then area measured for 20 cells/sample. Average areas are shown with standard deviations. On the right of the dotted line, measurements are shown for cells on laminin for 24 h. In (b), the number of individual cells having the speci®ed area range is shown for one NHSC specimen and two dierent schwannomas. The large range in area of individual schwannoma cells causes the large standard deviations in a the small GTP-binding protein Rac. Inactivation of Rho by C3 transferase, which catalyzes the ADP ribosylation of Rho, blocks the assembly of stress ®bers in ®broblasts (Paterson et al., 1990; Hirao et al., 1996) . C3 transferase has no eect on other members of the Ras superfamily including Rac. The ®nding that stress ®bers and membrane ruing are abundant in schwannoma cells suggested that some aspect of the Rac and/or Rho signaling pathways was altered in schwannoma cells. To test this prediction, we used cationic lipids to deliver C3 transferase to Schwann cells. Cells were then plated onto laminin in the presence of serum for 3 h followed by double labeling with phalloidin and S100b. When NHSC were treated with 10 mg/ml of C3, they failed to form detectable stress ®bers and, as anticipated for cells with reduced stress ®bers, were slightly rounded and less adherent than cells treated with cationic lipids only (not shown). In contrast, schwannoma cells did not change remarkably. This result suggested either that merlin was downstream of Rho in a signaling pathway, or that the dose of C3 was insucient to reverse Rho's eects. To discriminate between these possibilities, C3 was added to schwannoma cells at 30 mg/ml, and cells were stained with phalloidin and anti-S100b. As shown in Figure 5b , schwannoma cells lost stress ®bers at this higher C3 transferase concentration. This result suggests that Rho activity is higher in schwannoma cells than in NHSC, or that C3 enters schwannoma cells with decreased eciency. Consistent with loss of stress ®bers, schwannoma cells treated with 30 mg/ml C3 transferase lost focal adhesions detectable by staining with anti-paxillin (Figure 5c,d) .
Another test of involvement of Rho in the schwannoma stress ®ber phenotype is to treat cells with tyrphostin A25, a tyrosine kinase inhibitor thought to inhibit an enzyme that acts in ®broblasts upstream of Rho-GTP (Nobes et al., 1995) . As previously shown for ®broblasts (Chrzanowska-Wodnicka and Burridge, 1996) , when tyrphostin A25 was added to schwannoma cells for 30 min, and treated cells plated onto laminin in the presence of serum, no inhibition of stress ®bers was detected (Figure 6a and b) . However, when tyrphostin A25 was added to schwannoma cells plated onto laminin in de®ned N2 medium supplemented with the serum factor LPA, tyrphostinA25 blocked stress ®ber formation (Figure 6c and d) . The tyrosine kinase inhibitors genistein, at concentrations up to 50 mM and herbimycin at concentrations up to 50 nM did not block stress ®ber formation when cells were plated in serum or in the presence of LPA (these inhibitors were tested on cells from three schwannomas; not shown). These inhibitors have been variably eective in other systems (Chrzanowska-Wodnicka and Burridge, 1996; Ridley and Hall, 1994) .
To directly test whether blocking Rho could reverse stress ®ber formation in schwannoma cells, we introduced a dominant negative form of RhoA (dnRhoA) into NHSC and schwannoma cells using a recombinant adenovirus. Infected cells were replated onto laminin-coated coverslips for 30 min or 3 h, then triple labeled using anti-S100, anti-RhoA (to verify expression) and BODIPY-phalloidin. Cells overexpressing dnRhoA were rounded at both times (Figure 5e and f) . Indeed, few cells attached to the coverslips. Infected cells contained dramatically reduced F-actin (Figure 5f ). NHSC infected with dnRhoA showed a phenotype (not shown), similar to that obtained using C3 transferase. In contrast, NHSC and schwannoma cells infected with an adenovirus carrying LacZ were unaected in stress ®ber formation (not shown). 
Dominant negative Rac inhibits formation of ruing membranes in schwannoma cells
A number of experiments were carried out to test if the schwannoma ruing phentype required the Rac signaling cascade . PI 3-kinase has been implicated in regulation of the actin cytoskeleton in response to growth factor stimulation (Nobes et al., 1995; Rodriguez-Viciana et al., 1997) and acts upstream of Rac. To determine if PI 3-kinase activity was necessary for the ruing phenotype in schwannoma cells, we treated the schwannoma cells with the speci®c PI 3-kinase inhibitor, LY294002. No alterations in membrane ruing were detectable at To directly test if Rac is required for schwannoma cell membrane ruing, NHSC or schwannoma cells were infected using a recombinant adenovirus encoding dominant negative Rac (dnRac1) or a control virus encoding LacZ. Neither NHSC (not shown) nor schwannoma cells (Figure 7a and b) were detectably altered by expression of the control virus. However, as shown in Figure 7c and d, at 30 min after plating onto laminin, expression of the dnRac dramatically inhibited schwannoma cell ruing. Whereas 91% of schwannoma cells expressing LacZ showed membrane rules, only 10% of schwannoma cells expressing dnRac showed rues. Indeed, many schwannomma cells expressing the dnRac demonstrated ®lopodial-like extentions. NHSC expressing dnRac never showed ®lopodial extensions (Figure 7e and f) .
The eects of dnRac1 on schwannoma cells were even more dramatic 3 h after plating cells onto laminin. From one tumor, none of the 100 schwannoma cells expressing LacZ showed ®lopodial extensions. In contrast, 72 of 104 schwannoma cells (69%) expressing dnRac showed dramatic ®lopodia (Figure 7g and h ). Uninfected cells in the same culture maintained the abnormal stress ®ber phenotype described above. These data are consistent with the notion that altered Rac and Rho activity contribute to the abnormal cytoskeletal organization of schwannoma cells.
Ezrin and Moesin are expressed at normal levels in schwannoma cells
It is possible that in the predicted absence of merlin, other ERM proteins have altered expression in schwannoma cells. We aimed, therefore, to determine whether normal Schwann cells express other ERM proteins, and to ascertain whether this expression is signi®cantly altered in schwannoma cells. Levels of the ERM proteins ezrin and moesin were therefore analysed by Western blotting using an antibody recognizing ezrin (77 kd) and moesin (81 kd) . Figure 8 shows that NHSC and cells from two dierent schwannomas contain roughly equivalent levels of ezrin and moesin, consistent with the notion that other ERM proteins do not compensate for the lack of merlin in schwannomas. Similarly, a recent study demonstrated that other ERM proteins are detectable in rapidly frozen schwannomas lacking merlin (Stemmer-Rachamimov et al., 1997). After plating onto laminin-coated coverslips, cells were exposed to serum for 3 h (a,b) or to 100 ng/ml LPA for 2 h (c,d). Cells were ®xed and then double labeled with anti-S100b and BODIPY-phalloidin. Data are representative of experiments using tumors #5 and #2. Bar=10 microns
Discussion
In this study, we demonstrated that human schwannoma cells, which typically have mutations in the NF2 tumor suppressor gene, have altered growth properties and abnormal cytoskeletal organization. This is the ®rst demonstration of cellular abnormalities in human schwannoma cells. Since both sporadic and NF2 patient schwannoma cells lack functional merlin, our data are consistent with the hypothesis that the merlin protein plays a role in maintaining Schwann cell cytoskeletal organization and growth control. Experiments are in progress to test if re-introduction of dierent combinations of merlin splice variants is sucient to reverse some or all of the novel phenotypes we have identi®ed.
Figure 7 Dominant negative Rac (dnRac) inhibits schwannoma cell membrane ruing. Schwannoma cells (a ± d,g ± h) and NHSC (e,f) were infected with an adenovirus encoding either lac Z or myc-tagged dnrac, plated onto laminin then stained with either antib-galactosidase (a), anti-myc (c,e,f), or BODIPY-phalloidin (b,d,f,h). Note that after 30 min., schwannoma cells infected with dnRac lost membrane ruing and displayed ®lopodia (c-d, arrows) while uninfected cells in the same ®eld (c-d) or cells infected with lac Z (a-b) still displayed ruing membranes. At 3 h, NHSC infected with dnRac (e-f, arrows) and uninfected schwannomas (g-h) displayed extensive stress ®bers, while infected schwannomas lacked stress ®bers and displayed extensive ®lopodia (g-h, arrows). Data were gathered on tumors #17 and 18. Bar=10 mM Consistent with previous ®ndings in schwannoma tissue sections (Kawahara et al., 1988; Johnson et al., 1988) we found that cells obtained from both normal human nerves and from schwannomas had attributes characteristic of Schwann cells, including expression of the Schwann cell markers S100 protein and p75NGFR. The ®nding that the vast majority of cells obtained from multiple schwannomas expressed Schwann cell markers demonstrates the feasibility of obtaining suciently pure cell populations for biochemical analyses.
We showed that schwannoma cells, like normal human Schwann cells and neuro®broma Schwann cells (Baron and Kreider, 1991) , interact with processes of sensory neurons. We conclude that the defect in schwannoma cells does not prevent them from interacting with axons, even though within schwannomas the same cells are associated entirely with matrix. Indeed, schwannoma cells showed striking abnormalities in cell spreading upon interaction with matrix proteins. The cell spreading phenotype we identi®ed in schwannoma cells suggests enhanced adhesion of schwannoma cells to matrix. In contrast, Huynh and Pulst (1996) showed that down-regulation of merlin in a malignant Schwann cell tumor line resulted in decreased adhesion to matrix. The discrepancy between these data is likely due to dierences in the types of cells examined (e.g. benign vs malignant).
Abnormal ruing and induction of disorganized actin ®laments were also induced in schwannoma cells by contact with matrix proteins. These changes were speci®c to schwannoma cells since they were not detected in normal human Schwann cells, nor in cells from neuro®bromas. Schwannoma cells plated onto polyornithine also did not show either ruing or disorganized stress ®bers. Our data are consistent with a requirement for integrin-dependent signaling pathways in the induction of schwannoma phenotypes. Schwann cells express speci®c matrix-binding integrins that are required for establishment of Schwann cell polarity and myelination (Einhaber et al., 1993; Feltri et al., 1994; Fernandez-Valle et al., 1994 Jaakkola et al., 1993) . We predict, therefore, that schwannoma cells should abnormally ensheath axons and should fail to establish polarity.
Schwannoma cells had up to 10 times the spread area of NHSC, but were variable in size. This size variability was apparent even 24 h after plating onto matrix proteins. It is therefore unlikely that dierences in schwannoma cell size result from the timing of interactions of individual cells with matrix. Cultured cells that diered in size may have originated from dierent regions within the tumor microenvironment. Consistent with this idea, schwannomas contain Antoni A and Antoni B regions, within which schwannoma cell histology and ultrastucture dier (Cravioto, 1969; Kawahara et al., 1988; Johnson et al., 1988; Wechsler and Hossman, 1965; Erlandson and Woodru, 1982; Sobel, 1993) . Schwannoma cells of varying morphologies in culture have been noted previously (Cravioto and Lockwood, 1969) .
We found that cells from some schwannomas proliferated in the absence of added growth factors. Our experiments were conducted on laminin substrates. Normal Schwann cells proliferate in response to laminin, but only in the presence of serum (McGarvey et al., 1984) . Whether schwannoma cell proliferation is speci®c to interactions with laminin or might also be detectable on additional substrates is not yet known. Laminin is a major constituent of the matrix in schwannomas (d'Ardenne et al., 1984; McComb et al., 1985) , so abnormal response of schwannoma cells to laminin could contribute to tumor growth. Schwannoma cells from ®ve schwannomas we evaluated showed increased proliferation compared to NHSC under these conditions. Cells from two other schwannomas showed no such dierences. There is therefore no correlation between schwannoma cell proliferation in vitro and the cytoskeletal changes in schwannoma cells, as cytoskeletal changes were detected in cells from all of the tumors evaluated in this study.
Dierences in growth rates among schwannomas could be due to dierent NF2 mutations. Indeed, mild NF2 phenotypes are correlated with mutations that preserve the C-terminus of merlin while most families with severe phenotypes have mutations predicting expression of truncated merlin (Merel et al., 1995; Parry et al., 1996) . However, no truncated merlin was found in 13 schwannoma lysates analysed by Gutmann et al. (1997a) , or 22 lystates analysed by StemmerRachamimov et al. (1997) . Huynh et al. (1997) found staining of a subset of schwannomas using an Nterminal antibody (4/29) but no staining was observed with the C-terminal antibody. Thus if truncated forms of merlin exist in schwannomas, they are rare. More likely explanations of our results are that growth heterogeneity re¯ects the growth state of the tumors at the time of surgery, and/or mutations in other genes.
Normal human Schwann cells predominantly express the neuregulin receptors HER2 and HER3 . Our ®nding that schwannoma cells respond to neuregulin by proliferation is consistent with the idea that schwannoma cells also express neuregulin receptors. Schwann cells themselves produce neuregulins (Raabe et al., 1996; , and a neuregulin-like activity was partially puri®ed from human schwannomas (Brockes et al., 1986) . Aberrant neuregulin production or response could therefore also contribute to the aberrant 3) were lysed and subjected to SDS gel electrophoresis (100 mg protein loaded). Proteins were transferred to a PVDF membrane and the blot was probed with antibody B31 recognizing ezrin and moesin . To control for loading, parallel samples were probed with anti-N-cadherin schwannoma cell proliferation noted in cells from some schwannomas.
Little is known about how the actin cytoskeleton is regulated in Schwann cells. In several other types of cells, small GTP-binding proteins of the Rho family integrate extracellular signals and regulate actin organization (Tapon and Craig and Johnson, 1996) . Constitutively activated and dominant negative forms of Rho as well as the drugs C3 transferase and tyrphostin A25 have been used to demonstrate that Rho family members induce stress ®ber formation ChrzanowskaWodnicka and Burridge, 1996) . We demonstrated that C3 transferase, tyrphostin A25, or dnRhoA added to NHSC or schwannoma cells inhibited stress ®ber formation and adhesion to matrix. Our data indicate that the cytoskeletal abnormalities we de®ned require Rho activity. The merlin-related ERM proteins colocalize with Rho (Takaishi et al., 1995) , and Rho-GDI is found associated with a CD44/ERM complex (Hirao et al., 1996) . Mackay et al. (1997) showed that ERM proteins together with Rho-GTP activate stress ®ber formation in permeabilized Swiss 3T3 cells; schwannoma cells, presumably lacking merlin, also show increased stress ®bers. Our data are consistent with a growing body of evidence suggesting a role for ERM proteins in Rho signaling cascades.
Ruing membranes were another prominent feature of schwannoma cells that bind to matrix. In other cell types, Rac family members induce membrane rues . Consistent with Rac activation in schwannoma cells, we showed that dnRac dramatically inhibited membrane ruing in schwannoma cells. Although we were unable to reverse membrane ruing with an inhibitor of PI3 kinase, LY294002, which should block upstream of Rac, some cell types apparently contain LY294002-resistant forms of PI3Kinase (Rodriguez-Viciana et al., 1997). Our data imply that the Rac, as well as the Rho, signaling pathways are activated in schwannoma cells, and provide a model to study how these pathways contribute to Schwann cell tumorigenesis.
Materials and methods
Patient information
Five normal human nerve specimens, sixteen schwannomas, and one neuro®broma were used in these studies. Table 2 shows the age and sex of the patients from whom the specimens were obtained at autopsy or incidental to therapeutic surgery or trauma. Also shown is the location of each tumor (for schwannomas) or the nerve which was dissociated (normal samples). Each sample was designated by an arbitrary number which is referred to througout the text. Patient diagnoses of NF2 were carried out according to established criteria of family history, MRI of the brain, and physical and opthalmologic evaluations (Gutmann et al., 1997b) .
Normal human schwann cell cultures
Normal human cauda equina were donated by the University of Miami Organ Procurement Team (Miami, FL). A sural nerve was obtained from the Columbus Human Tissue Network (CHTN; Columbus, OH). Schwann cells were puri®ed by a protocol modi®ed from Rutkowski et al. (1992) . Nerves were incubated for 5 ± 7 days at 7.5% CO 2 in 20 ml medium per 5 grams. Medium consisted of Dulbecco's Modi®ed Eagle Medium (DMEM; high glucose and glutamine, Gibco) supplemented with 10% FBS (heat treated; Harlan), penicillin-streptromycin (50 U/ml penicillin; 50 (mg/ml streptomycin, Gibco), 14 ng/ml of recombinant human glial growth factor (rhGGF2; Cambridge Neuroscience; Marchionni et al., 1993) and 2 mM forskolin (Calbiochem). This medium was replaced with fresh medium every 2 days. Nerves were then dissociated by incubation for 4 ± 6 h in Liebowitz's medium (L15; Gibco) with 0.05% collagenase (Worthington Biochemicals), 1.25 U/ml dispase (Boehringer-Mannheim) and gentamicin (50 mg/ml) at 378C. The enyzme solution together with dissociated material was diluted with 50 ml of medium, then centrifuged to pellet cells and debris. The pellet was resuspended in 10 ± 20 ml of de®ned serum free N2 medium containing 50 mg/ml gentamicin, triturated several times with a narrowed-bore pasteur pipette and plated onto two T75 asks coated with 50 mg/ml poly-l-lysine (Sigma) per each 2.5 ± 5 g of nerve. Cells were incubated with N2 medium supplemented with 14 ng/ml rhGGF2, 2 mM forskolin and 50 mg/ml gentamicin (growth medium) for a further 3 ± 5 days. Floating debris was then removed from cultures, centrifuged to pellet the debris, resuspended in N2 medium as above, then replated onto one new T75¯ask coated with poly-l-lysine for each original 2.5 ± 5 g nerve. This further enriched the Schwann cell population, because many ®broblasts adhered to the original dishes (Morrissey et al., 1991) . From these initial cultures, termed passage 0 (P0), NHSC could be expanded for an additional 3 ± 5 passages, changing the growth medium every 3 days. From 
+ cells were determined from cells that had been plated onto laminin-coated coverslips and cultured for 5 days in de®ned medium with rhGGF2 (see Materials and methods). Cells were then ®xed and stained with anti-S100 and both S100 positive and negative cells were counted under bright ®eld optics to calculate the percentage of Schwann cells. ND=Cells from these tumors were not speci®cally analysed for %S n.d. S100
+ and S100 7 cells but had similar purity to those analysed, except for the neuro®broma which was about 50% S100 + cells a typical 5 gm nerve sample we obtained 3 ± 10610 6 cells by passage 2.
Tumor schwann cells
Schwannomas were obtained incidental to surgery. Tumors (typically weighing 100 ± 500 mg) were collected into cold DMEM medium with 10% fetal calf serum and antibiotics, and minced into *1.5 mm cubes with a razor blade. Each schwannnoma was dissociated for 3 h in 20 ml of dissociation medium (L15 with 0.05% collagenase and 1.25 U/ml dispase) at 378C. The enyzme solution together with dissociated material was diluted with 50 ml of serumcontaining medium, then centrifuged. The pellet was resuspended in 10 ± 20 ml of N2 medium containing 50 mg/ml gentamicin, gently triturated several times with a pasteur pipette (no narrowing of the pipette bore) before plating the cells. Each dissociated tumor was plated onto a single poly-l-lysine coated 60 mm culture dish containing growth medium as described for NHSC. Any bits of tumor that did not settle after 3 days were removed from the dish with the medium, centrifuged to pellet, triturated gently and then replated onto new dishes; this often resulted in adherence and expansion of Schwann cells from pieces of tumor. As with the NHSC cultures, culture medium was changed every 3 days. We typically obtained 1 ± 2610
6 cells per tumor sample by passage 2. The percentage of tumors yielding viable cells was about 50%.
Laminin coated coverslips
Glass coverslips (12 mm; Bellco) were coated with laminin by diluting commercial laminin (1 mg/ml; Sigma or ICN) to 10 mg/ml with PBS, then applying 50 ± 100 ml/coverslip. Coverslips were maintained at 48C overnight, drained then placed, without rinsing, into 24 well dishes and the excess laminin was removed by aspiration. Cells were trypsinized, pelleted in DMEM with 10% fetal calf serum, then resuspended in N2, counted in a hemocytometer, and plated as a 20 ml drop containing designated numbers of cells onto each drained coverslip. Ten to 15 min after plating the wells were¯ooded the with appropriate medium.
Schwann cell proliferation assay
NHSC and schwannoma cells (passage 2 or 3 only were used for proliferation assays) were removed from dishes by trypsinization, pelleted, resuspended in N2 and plated as a 20 ml drop containing approximately 10 000 cells onto laminin-coated drained coverslips. Cells were allowed to settle for 15 min before wells were¯ooded with 0.5 ml of growth medium. Cells were left overnight and the next day the medium was replaced with N2. Two days later, the medium was switched to either N2 or N2 plus 14 ng/ml rhGGF2. Eighteen hours later, the cells were pulsed with [ 3 H]thymidine (2 mCi/ml) for 3 days. The cells were ®xed in 4% paraformaldehyde and immunostained with antiS100b. Stained cells were processed for autoradiography , developed and labeled nuclei of S100-positive Schwann cells counted.
Neuron-schwann cell co-cultures
Rat embryonic day 15 dorsal root ganglion (DRG) neuron cultures were freed of endogenous non-neuronal cells by antimitotic treatment as previously described . Between 10 and 25 thousand Schwann cells were seeded onto the established neurons in DMEM plus 10% human placental serum (HPS) and 50 ng/ml NGF (Harlan). After 1 or 3 days, co-cultures were ®xed and immunostained using an anti-p75 or anti S100b antibody.
Following immunostaining, the neuron cell bodies and neurites were counterstained in toluidine blue.
Antibody staining and microscopy
For immuno¯uorescence, cells were ®xed by gently removing medium and immersing without rinsing in 4% paraformaldehyde in PBS for 20 min at room temperature. Cultures were then blocked in PBS with 10% normal goat serum. If permeablization was necessary, 0.2% Triton X-100 was added in the blocking buer (for anti-S100 and anti-paxillin). Primary antibodies were rabbit anti-S100b (1 : 6000, 1 h at room temperature; Dako), mouse antihuman p75 (conditioned medium, overnight at 48C; Ross et al., 1984) or anti-paxillin (1 : 1000 overnight at 48C; Transduction Labs). Cultures were then washed and incubated with a 1 : 200 dilution of TRITC-conjugated goat anti-rabbit IgG (Jackson Labs) (for anti-S100b) or TRITC-conjugated goat anti-mouse IgG (Jackson Labs) (for anti-p75 or anti-paxillin). To visualize actin ®laments, BODIPY-conjugated phalloidin (Molecular Probes; 0.2 units in 50 ml) was included in the 40 min incubation with secondary antibodies. Coverslips were mounted in 1 drop of Fluoromount G (EM Sciences, Ft. Washington, PA). Cells were viewed on a Zeiss Axiophot microscope and photographed with Kodak P3200 ®lm. For immunostaining of Schwann cells in neuron co-cultures, proliferation assays and in cultures to calculate percentages of Schwann cells, cultures were ®xed, blocked, and incubated in primary as above, except that anti-S100b was used at a concentration of 1 : 4000 for schwannoma cells and 1 : 8000 for NHSC. Detection was achieved using goat anti-rabbit secondary antibody coupled to horseradish peroxidase and the ABC staining kit according to manufacturer's directions (Vector Labs). Cultures were photographed with Royal Gold Kodak ®lm (25ASA).
Cell surface area measurements
Cells were plated onto laminin or human ®bronectin (100 mg/ml; Collaborative Biosciences)-coated coverslips. Fibronectin-coated coverslips were prepared as described above for laminin. Some coverslips were treated with rat tail collagen exposed to ammonia vapors and then air dried . Two to ®ve thousand cells were plated onto individual coverslips, allowed to settle for 15 min, then incubated in the presence of N2 plus 10% HPS for 3 or 24 h. The cells were then ®xed in paraformaldehyde and stained using anti-S100 as described above. Stained cells were visualized under bright ®eld optics and spread areas measured by tracing the perimeter of the cells and calculating the areas using the NIH Image Analysis software. For each determination, the spread areas of 20 S100-positive cells were measured.
Drug treatments of cells
C3 exoenzyme puri®ed from clostridium botulinum (Biomol) (0, 10 or 30 mg) in 5 mM HEPES buer was incubated for 15 min at room temperature with 30 mg of DOTAP (Gibco-BRL), then N2 medium was added to a ®nal volume of 100 ml. Cell pellets containing 5 ± 10 000 cells were resuspended in this medium. This method was based on that of Jalink et al. (1994) . Cells were incubated in suspension for 30 min, then plated onto laminin-coated coverslips and left for 2 h. For experiments in which serum was present, it was added at the time of plating. After 2 h, the cells were ®xed and labeled with anti-S100 and phalloidin as described above.
Herbimycin A was used at 1 ± 50 nM, genistein at 10 100 mg/ml, and LY294002 at 10 ± 50 mM (all from Calbiochem). Tyrphostin A25 was used at 150 mM and was from Biomol. These drugs were added to cells in suspension in N2 medium for 1 h (except for tyrphostin which was added for 30 min). Cells were then pelleted and resuspended in 60 ml medium; 30 ml aliquots containing 5000 cells were plated onto laminin-coated coverslips. Cells were allowed to settle for 10 min, then coverslips were¯ooded with N2 plus 10% serum for 3 h. For all drug studies, parallel cell preparations were treated with vehicle only (0.3% DMSO for herbimycin, genistein, and LY294002 and tyrphostin A25), and drug was continuously present during plating of cells and serum exposure. Cells were ®xed and analysed as above. In experiments using LPA, 100 ng/ml lysophosphatidic acid (Sigma) was added to cells after they had settled onto coverslips for 1 h in N2 medium; LPA was present for 2 h after which cells were ®xed and analysed.
Adenoviral constructs and infections
Recombinant adenoviruses were a gift from D Kalman (UCSF), and are described fully in Hardy et al. (1997) and Kalman D, Gompert S, Hardy S, Kitamura M and Bishop JM (submitted). Expression of N17RhoA, or myc-taggedN17Rac1, was driven by a minimal promoter containing tetracycline-repressor binding sites. Expression of recombinant proteins required co-infection of Schwann cells and schwannoma cells with a second virus, constitutively expressing a tetracycline-VP16 fusion protein, under control of a CMV promoter; this virus was used at a ®nal titre of 8.3610 6 p.f.u./ml. Final viral titre for N17RhoA was 1.3610 7 p.f.u./ml, and myc-taggedN17Rac1 was 1.3610 6 p.f.u./ml or 1.3610 7 p.f.u./ml, in a volume of 300 ml. Similar results were obtained at both concentrations. Recombinant LacZ viral titre was 2.7610 6 p.f.u./ml, also in 300 ml. Viruses were applied to NHSC or schwannoma cells on coverslips within 24 well dishes for 2 h. Cells were then washed twice, and maintained in N2 with rhGGF2 and forskolin for 48 h. Cells were then removed from coverslips using trypsin, and replated onto laminin for 30 min or 3 h as above, then ®xed. Cells were analysed using a triple-label immunohistochemistry paradigm, using AMCA-labeled anti-rabbit secondary (Molecular Probes) to detect anti-S100, rhodamine-labeled antimouse to detect mouse anti-myc (Anti-myc was from ATTC) or anti-RhoA (Santa Cruz) or anti-b-galactoside (Promega), and BODIPY-phalliodin. Controls included coverslips to which no primary antibody was added together with anti-mouse secondary.
Western blotting
Schwann cells or schwannoma cells were plated onto polyl-lysine coated 60 mm dishes (0.5610 6 /dish) for 2 days in serum-free medium. Cells were rinsed brie¯y in ice-cold PBS, then lysed in 0.5 ml RIPA buer (25 mM Tris-HCl, pH 7.4, 0.15 M NaCl, 1 mM EDTA, 1% Na desoxycholate, 1% Triton X-100, 0.1% SDS) with the addition of 10 mg/ ml leupeptin, 1 mM phenylmethylsulfonyl¯uoride, and 10 mg/ml pepstatin A. Protein was determined by a modi®ed Lowry assay (Markwell et al., 1978) and 100 mg protein loaded onto 7.5% acrylamide gels. Proteins were transferred to PVDF membrane, blocked in 5% non-fat dry milk in PBS and probed with anti-N-cadherin (1 : 500 dilution of rabbit anti-pancadherin; Sigma) or anti ezrin/ moesin (1 : 2000 dilution of antibody B31; Franck et al., 1993) . Blots were washed and stained with alkaline phosphatase-linked secondary antibodies (Biorad); color development was according to Blake et al. (1984) .
